Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01504477 · ClinicalTrials.gov registry record · Phase 1
Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
A Phase 1 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01504477 is a Phase 1 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 6 participants.
The verdict
NCT01504477, a Phase 1 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
Panitumumab plus bortezomib for colon cancer
Interventions
- DRUG Panitumumab and bortezomib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01504477
The ClinicalTrials.gov registry entry for NCT01504477 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Panitumumab and bortezomib is the first listed.
NCT01504477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01504477 about?
NCT01504477 is a clinical study titled "Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer". Panitumumab plus bortezomib for colon cancer
What is the current status of trial NCT01504477?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2011-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01504477?
The interventions under investigation include: Panitumumab and bortezomib (DRUG).
Who is sponsoring clinical trial NCT01504477?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.